Original Research
Published on 16 Dec 2022
Three year results of Blessed: Expanded access for DeltaRex-G for an intermediate size population with advanced pancreatic cancer and sarcoma (NCT04091295) and individual patient use of DeltaRex-G for solid malignancies (IND# 19130)
in Molecular Medicine and Cancer Treatment
- 3,146 views
- 5 citations